Natural Products Company Has Another Postdoctoral Entry
Release time:
2020-10-23
Natural Products Company has another post-doctoral entrance examination
News 9# May 27 On the morning of the 7th, the entrance examination opening report of Dr. Li Dongnan of Shenyang Agricultural University was held in Tianjin Jianfeng Natural Products Company. This is the fifth doctor who has entered the station for postdoctoral research since the company's national postdoctoral workstation was established.
This post-doctoral research is part of the joint scientific research work carried out by the post-doctoral workstation of the natural product company and the post-doctoral mobile station of the School of Food Science and Engineering of Tianjin University of Science and Technology. Liu Dan, general manager of the natural product company, and Professor Zhang Zesheng of Tianjin University of Science and Technology Co-served as postdoctoral tutors.The research topic of Dr. Li Dongnan is the mechanism of pectin improving the stability of anthocyanin in fruit juice. In the opening report, he elaborated the basic content, expected goal, current situation at home and abroad, scientific significance, academic value, application prospect, technical route, innovation points and proposed key issues of the research, he also accepted questions from an expert group composed of Professor Du Xinjun, Dean of the School of Food Science and Engineering of Tianjin University of Science and Technology, and Zhang Chunli, a senior engineer of a natural product company. After a comprehensive discussion between the instructor and the expert group, Dr. Li Dongnan innovatively introduced high hydrostatic pressure technology into the research of this subject, and used the extreme pressure conditions generated by high hydrostatic pressure to change the hydrogen bond, ionic bond and hydrophobic interaction between anthocyanin-
pectin in fruit juice, the effect of different non-covalent binding forms on the stability of anthocyanins was explored by studying the relationship between the interaction differences of anthocyanins - and the stability of anthocyanins in the same system, and the mechanism of pectin improving the stability of anthocyanins in fruit juice was further clarified, which made it possible to quantitatively adjust the stability of anthocyanins in water-based environment by using endogenous substances in fruits and vegetables, and provided new ideas for improving the stability of active substances in water-based environment; the experimental design of this topic is scientific and reasonable, and the goal is feasible. The existing experimental equipment and facilities of the workstation can meet the experimental needs. Dr. Li Dongnan has the ability to undertake the research of this topic and agrees to enter the station to start the topic.
Tianjin Jianfeng Natural Products Company's national post-doctoral workstation was established in 2005. Up to now, 4 doctors have completed the research and successfully left the station. Some research results have been applied in product research and development and production. (Mu Ruixin)
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31